Aldeyra Therapeutics, Inc. (ALDX) stock

ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$0.64+0.01 (+2.17%)

Close on Nov 13, 2026Market cap $38.84MP/E –Yield –

Aldeyra Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Aldeyra Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?